Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein

Journal of Hepatology

Volumn 32, Issue 6, 2000, Pages 946-954

  Mita, Yuhsaku ^a   Aoyagi, Yutaka ^a,b   Suda, Takeshi ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Yutaka Aoyagi   (Japan)

Author keywords

Alpha fetoprotein; Fucosylation index; Fucosyltransferase; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; FUCOSYLTRANSFERASE;

ADULT; ARTICLE; CANCER STAGING; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0034084194     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80099-9     Document Type: Article

References (35)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ. 62:1984;163-183.
2. Okuda K. Primary liver cancer in Japan. Cancer. 45:1980;2663-2669.
3. Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res. 28:1968;1344-1350.
4. O'Conor GI, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer. 25:1970;1091-1098.
5. Karvountzis GG, Redeker AG. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Intern Med. 80:1974;156-160.
6. Chen D-S, Sung J-L. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer. 40:1977;779-783.
7. Alpert E, Feller ER. Alpha-fetoprotein (AFP) in benign liver diseases: evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology. 74:1978;856-858.
8. Aoyagi Y, Suzuki Y, Isemura M, Soga K, Ozaki T, Ichida T, et al. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann. 75:1984;809-815.
9. Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki T, et al. Fucosylated alphafetoprotein as marker of early hepatocellular carcinoma. Lancet. ii:1985;1353-1354.
10. Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki T, et al. Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells. Lancet. i:1986;210.
11. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer. 61:1988;769-774.
12. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. The usefulness of the simultaneous determination of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer. 67:1991;2390-2394.
13. Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, et al. Fucosylation index of α-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 17:1993;50-52.
14. Aoyagi Y. Carbohydrate-based measurement on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma. Glycoconjugate J. 12:1995;194-199.
15. Breborowicz J, Mackiewicz A, Breborowicz D. Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol. 14:1981;15-20.
16. Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology. 99:1990;508-518.
17. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, et al. A collaborative study for the evaluation of lectin-reactive alphafetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 53:1993;5419-5423.
18. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med. 328:1993;1802-1806.
19. Aoyagi Y, Isemura M, Yoshizawa Z, Suzuki Y, Sekine C, Ono T, et al. Fucosylation of serum alpha-fetoprotein with primary hepatocellular carcinoma. Biochim Biophys Acta. 830:1985;217-223.
20. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. Br J Cancer. 67:1993;486-492.
21. Lonmore GD, Schachter H. Product-identification and substratespecificity studies of the GDP-L-fucose: 2-acetamido-2-deoxy-β-D-glucoside (Fuc→Asn-linked GlcNAc) 6-α-L-fucosyltransferase in a Golgi-rich fraction from porcine liver. Carbohydrate Res. 100:1982;365-392.
22. Hutchinson WL, Du MQ, Johnson PJ, Williams R. Fucosyltransferase: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology. 13:1991;683-688.
23. Noda K, Miyoshi E, Uozumi N, Yanagidani S, Ikeda Y, Gao CX, et al. Gene expression of α1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology. 28:1998;944-952.
24. Yazawa S, Kochibe N, Nishimura T, Shima C, Takai I, Adachi M, et al. A novel method for determination of α1-6 fucosyltransferase activity using a reducing oligosaccharide from egg yolk as a specific acceptor. Glycoconjugate J. 15:1998;868-871.
25. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 3rd ed. 1992;Kinbara Shuppan Co. Ltd. Tokyo.
26. Sobin LH, Witterkind C. 5th ed. UICC TNM Classification of Malignant Tumors. 1997;John Wiley and Sons Inc. New York.
27. Uozumi N, Teshima T, Yamamoto T, Nishikawa A, Gao YE, Miyoshi E, et al. A fluorescent assay method for GDP-L-Fuc: N-Acethyl-β-D-glucosaminide α1-6 fucosyltransferase activity, involving high performance liquid chromatography. J Biochem. 120:1996;385-392.
28. Nakashima T. Vascular changes and hemodynamics in hepatocellular carcinoma. Okuda K, Peters RL. Hepatocellular Carcinoma. 1976;169-203 John Wiley & Sons, New York, London, Sydney, Toronto.
29. Sekine C, Aoyagi Y, Suzuki Y, Ichida F. The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin and its usefulness in the diagnosis of neoplastic diseases of the liver. Br J Cancer. 56:1987;371-375.
30. Saitoh A, Aoyagi Y, Asakura H. Structural analysis on the sugar chains of alpha-L-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. Arch Biochem Biophys. 303:1993;281-287.
31. Suzuki Y, Aoyagi Y, Mori S, Suda T, Naitoh A, Isokawa O, et al. Microheterogeneity of serum transferrin in the diagnosis of hepatocellular carcinoma. J Gastroenterol Hepatol. 11:1996;358-365.
32. Hase S, Ibuki T, Ikenaka T. Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J Biochem. 95:1984;197-203.
33. Uozumi N, Yanagidani S, Miyoshi E, Ihara Y, Sakuma T, Gao CX, et al. Purification and cDNA cloning of porcine brain GDP-L-FUC:N-Acetyl-β-D-glucosaminide α1-6 fucosyltransferase. J Biol Chem. 271:1996;27810-27817.
34. Koscielak J, Pacuszka T, Kubin J, Zdziechowska H. Serum α-6-L-fucosyltransferase is released from platelets during clotting of blood. Glycoconjugate J. 4:1987;43-49.
35. Tsuji T, Osawa T. Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets. J Biochem. 100:1986;1387-1398.